Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1 /

This study aimed to identify and validate novel autoantibodies that reflect global and organ-specific disease activity in systemic lupus erythematosus (SLE).Plasma samples were screened for IgG and IgA seroreactivity against 1609 protein autoantigens using a microarray (i-Ome Discovery; Sengenics)....

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Lindblom Julius
Lagutkin Denis
Sherina Natalia
Idborg Helena
Beretta Lorenzo
Borghi Maria Orietta
Peyper Janique M
Barturen Guillermo
Jakobsson Per-Johan
Alarcón-Riquelme Marta E
Nikolopoulos Dionysis
Parodis Ioannis
Kovács László
Balog Attila
Deák Magdolna
Bocskai Márta
Dulic Sonja
Kádár Gabriella
Kollaborációs szervezet: PRECISESADS Clinical Consortium
et al
Dokumentumtípus: Cikk
Megjelent: 2025
Sorozat:ANNALS OF THE RHEUMATIC DISEASES 84 No. 7
Tárgyszavak:
doi:10.1016/j.ard.2025.04.008

mtmt:36162434
Online Access:http://publicatio.bibl.u-szeged.hu/36899
Leíró adatok
Tartalmi kivonat:This study aimed to identify and validate novel autoantibodies that reflect global and organ-specific disease activity in systemic lupus erythematosus (SLE).Plasma samples were screened for IgG and IgA seroreactivity against 1609 protein autoantigens using a microarray (i-Ome Discovery; Sengenics). We determined differentially abundant autoantibodies (daAAbs) in patients with SLE vs healthy controls within a discovery (n = 196 vs n = 110; NTC02890121) and an independent validation cohort (n = 30 vs n = 83; NCT02890134) from the European PRECISESADS project. Validated daAAbs were analysed in relation to global and organ-specific disease activity using linear and logistic regression, along with daAAb target pathway enrichment analysis.We validated 89 IgG and 66 IgA daAAbs. IgG anti-LIN28A, IgG anti-HMGN5, and both isotypes for anti-IRF5 and anti-TGIF1 were associated with a SLE disease activity index 2000 score of ≥10, negatively associated with lupus low disease activity state, and highly prevalent in subgroups with active disease across organ manifestations. IgG anti-LIN28A levels exceeded the cutoff for positivity in 53% of patients with central nervous system (CNS) involvement, a prevalence higher than that observed for anti-double-stranded DNA (20%) and 47% of patients with renal activity. A cluster of IgG and IgA daAAbs against RNA-binding proteins, including anti-LIN28A, was linked to CNS involvement. IgA anti-FOSL2 was elevated uniquely in patients with musculoskeletal activity. Enriched pathways involving DNA binding and repair showed considerable overlap across manifestations.Novel IgG and IgA autoantibodies, including IgG anti-LIN28A, IgG anti-HMGN5, IgG and IgA anti-IRF5, and IgG and IgA anti-TGIF1 were associated with SLE disease activity and highly abundant across organ manifestations.
Terjedelem/Fizikai jellemzők:1164-1179
ISSN:0003-4967